Skip to main content
Clinical Trials/NCT04215692
NCT04215692
Suspended
N/A

Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients

Instituto Mexicano del Seguro Social1 site in 1 country68 target enrollmentNovember 1, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fluid Overload Pulmonary Edema
Sponsor
Instituto Mexicano del Seguro Social
Enrollment
68
Locations
1
Primary Endpoint
Length of stay
Status
Suspended
Last Updated
last year

Overview

Brief Summary

A randomized clinical trial to evaluate the effect of using pulmonary ultrasound to guide fluid therapy on distinct variables.

Detailed Description

In this randomized clinical trial, the investigators will evaluate the effect of guiding fluid therapy by pulmonary ultrasound on the following variables: Length of stay in the pediatric ICU Duration of mechanical ventilation Oxygenation index PaO2/FiO2

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
December 28, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Juan Manuel Marquez Romero

Principal Investigator

Instituto Mexicano del Seguro Social

Eligibility Criteria

Inclusion Criteria

  • All pediatric inpatient intensive care unit admissions
  • Signed Informed Consent Form

Exclusion Criteria

  • Cyanotic congenital heart disease
  • Not requiring mechanical ventilation

Outcomes

Primary Outcomes

Length of stay

Time Frame: through study completion, an average of 14 days

Number of days that the patient requires care in the ICU

Secondary Outcomes

  • PaO2/FIO2(Daily through study completion, an average of 14 days)
  • Oxygenation Index(Daily through study completion, an average of 14 days)
  • Duration of mechanical ventilation(through study completion, an average of 14 days)

Study Sites (1)

Loading locations...

Similar Trials